Feasibility Study of Nivolumab and Docetaxel in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer

被引:0
|
作者
Shimokawa, T. [1 ]
Nakamura, Y. [1 ]
Iwasawa, S. [2 ]
Miyazaki, K. [3 ]
Yamanaka, T. [4 ]
Takiguchi, Y. [2 ]
Okamoto, H. [1 ]
机构
[1] Yokohama Municipal CitizenS Hosp, Dept Resp Med, Yokohama, Kanagawa, Japan
[2] Chiba Univ Hosp, Chiba, Japan
[3] Yokohama Municipal CitizenS Hosp, Yokohama, Kanagawa, Japan
[4] Yokohama City Univ, Sch Med, Yokohama, Kanagawa, Japan
关键词
nivolumab plus docetaxel; non-small cell lung cancer;
D O I
10.1016/j.jtho.2017.11.101
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P2.07-042
引用
收藏
页码:S2431 / S2431
页数:1
相关论文
共 50 条
  • [1] Feasibility study of nivolumab and docetaxel in previously treated patients with advanced non-small cell lung cancer
    Miyazaki, Kazuhito
    Iwasawa, Shunichiro
    Nakamura, Yukiko
    Shimokawa, Tsuneo
    Yamanaka, Takeharu
    Takiguchi, Yuichi
    Okamoto, Hiroaki
    ANNALS OF ONCOLOGY, 2017, 28
  • [2] Nivolumab Versus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer and Liver Metastases
    Crino, L.
    Horn, L.
    Felip, E.
    Frontera, O. Aren
    Burgio, M.
    Waterhouse, D.
    Blumenschein, G.
    Barlesi, F.
    Garassino, M.
    Holgado, E.
    Antonia, S.
    Spigel, D.
    Gainor, J.
    Gettinger, S.
    Geese, W.
    Li, A.
    Healey, D.
    Ready, N.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2302 - S2302
  • [3] Comparative Effectiveness of Atezolizumab, Nivolumab, and Docetaxel in Patients With Previously Treated Non-Small Cell Lung Cancer
    Ramagopalan, Sreeram
    Gupta, Alind
    Arora, Paul
    Thorlund, Kristian
    Ray, Joshua
    Subbiah, Vivek
    JAMA NETWORK OPEN, 2021, 4 (11)
  • [4] Monotherapy with docetaxel in previously treated patients with advanced non-small cell lung carcinoma
    Courousis, C
    Androulakis, N
    Heras, P
    Vamvakas, I
    Metaxaris, G
    Souklakos, J
    Vlastos, F
    Dimadi, M
    Vossos, A
    Aravosita, P
    Georgopoulou, T
    Papandreou, A
    Hatzidaki, D
    Papadakis, E
    Georgoulias, V
    2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 571 - 574
  • [5] Statins improve survival in patients previously treated with nivolumab for advanced non-small cell lung cancer: An observational study
    Omori, Miwako
    Okuma, Yusuke
    Hakozaki, Taiki
    Hosomi, Yukio
    MOLECULAR AND CLINICAL ONCOLOGY, 2019, 10 (01) : 137 - 143
  • [6] Nivolumab Versus Docetaxel for Previously Treated Advanced Non-Small Cell Lung Cancer in China: A Cost-Effectiveness Analysis
    Qiao Liu
    Xia Luo
    Liubao Peng
    Lidan Yi
    Xiaomin Wan
    Xiaohui Zeng
    Chongqing Tan
    Clinical Drug Investigation, 2020, 40 : 129 - 137
  • [7] Nivolumab Versus Docetaxel for Previously Treated Advanced Non-Small Cell Lung Cancer in China: A Cost-Effectiveness Analysis
    Liu, Qiao
    Luo, Xia
    Peng, Liubao
    Yi, Lidan
    Wan, Xiaomin
    Zeng, Xiaohui
    Tan, Chongqing
    CLINICAL DRUG INVESTIGATION, 2020, 40 (02) : 129 - 137
  • [8] A FEASIBILITY STUDY OF VINORELBINE AND BEVACIZUMAB IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
    Kaburaki, Kyohei
    Isobe, Kazutoshi
    Yamamoto, Ai
    Tochigi, Naobumi
    Hata, Yoshinobu
    Shibuya, Kazutoshi
    Iyoda, Akira
    Homma, Sakae
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S887 - S887
  • [9] A phase IINCCTG study of irinotecan and docetaxel in previously treated patients with non-small cell lung cancer
    Molina, Julian R.
    Nikcevich, Daniel
    Hillman, Shauna
    Geyer, Susan
    Drevyanko, Timothy
    Jett, James
    Verdirame, Joseph
    Tazelaar, Henry
    Rowland, Kendrith
    Wos, Edward
    Kutteh, Leila
    Nair, Suresh
    Fitch, Tom
    Flynn, Patrick
    Stella, Philip
    Adjei, Alex A.
    CANCER INVESTIGATION, 2006, 24 (04) : 382 - 389
  • [10] Improved efficacy of ramucirumab plus docetaxel after nivolumab failure in previously treated non-small cell lung cancer patients
    Shiono, Ayako
    Kaira, Kyoichi
    Mouri, Atsuto
    Yamaguchi, Ou
    Hashimoto, Kosuke
    Uchida, Takahiro
    Miura, Yu
    Nishihara, Fuyumi
    Murayama, Yoshitake
    Kobayashi, Kunihiko
    Kagamu, Hiroshi
    THORACIC CANCER, 2019, 10 (04) : 775 - 781